First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
- Posted on January 5, 2026
- By CNBC
- 3 Views
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
